Who
John B. Henneman III
Director
Company insider
Files Form 4 as: Director, Anika Therapeutics; Director, Aprea Therapeutics; Director, Orthofix Medical; Director, R1 RCM Inc. /DE; Director, SeaSpine Holdings; Director, R1 RCM Holdco; Chief Administrative Officer, Newlink Genetics; CorpVP, CAO, Integra LifeSciences Holdings.
In numbers
- Trades disclosed
- 423
- Buys
- 8
- Sells
- 41
- Bought
- $854K
- Sold
- $23.9M
- Companies
- 8
- Companies where not an officer
- 6
- First trade
- 6 Jan 2006
- Last trade
- 18 Jun 2026
- Last filed
- 23 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 18 Jun 2026filed 23 Jun 2026 | ANIK Anika TherapeuticsMedical Devices | SEC FORM 4 Code A | —10,402 at $0.00 | filing |
| 18 Jun 2026filed 23 Jun 2026 | ANIK Anika TherapeuticsMedical Devices | SEC FORM 4 Code A | —10,402 at $0.00 | filing |
| 16 Jun 2026filed 17 Jun 2026 | APRE Aprea TherapeuticsBiotechnology | SEC FORM 4 Code A | —3,135 at $0.00 | filing |
| 16 Jun 2026filed 17 Jun 2026 | APRE Aprea Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,555 at $0.00 | filing |
| 16 Jun 2026filed 17 Jun 2026 | APRE Aprea Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,555 at $0.00 | filing |
| 16 Jun 2026filed 17 Jun 2026 | APRE Aprea TherapeuticsBiotechnology | SEC FORM 4 Code A | —3,135 at $0.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | OFIX Orthofix MedicalMedical Devices | SEC FORM 4 Code A | —14,965 at $0.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | OFIX Orthofix MedicalMedical Devices | SEC FORM 4 Code A | —14,965 at $0.00 | filing |
| 7 May 2026filed 8 May 2026 | OFIX Orthofix MedicalMedical Devices | SEC FORM 4 Bought | $61K5,000 at $12.26 | filing |
| 7 May 2026filed 8 May 2026 | OFIX Orthofix MedicalMedical Devices | SEC FORM 4 Bought | $61K5,000 at $12.26 | filing |
| 1 May 2026filed 4 May 2026 | ANIK Anika TherapeuticsMedical Devices | SEC FORM 4 Bought | $73K5,000 at $14.66 | filing |
| 1 May 2026filed 4 May 2026 | ANIK Anika TherapeuticsMedical Devices | SEC FORM 4 Bought | $73K5,000 at $14.66 | filing |
| 20 Jun 2025filed 24 Jun 2025 | ANIK Anika TherapeuticsMedical Devices | SEC FORM 4 Code A | —14,164 at $0.00 | filing |
| 18 Jun 2025filed 23 Jun 2025 | OFIX Orthofix MedicalMedical Devices | SEC FORM 4 Code A | —18,841 at $0.00 | filing |
| 5 Jun 2025filed 9 Jun 2025 | APRE Aprea Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —4,185 at $0.00 | filing |
| 5 Jun 2025filed 9 Jun 2025 | APRE Aprea TherapeuticsBiotechnology | SEC FORM 4 Code A | —1,045 at $0.00 | filing |
| 19 Nov 2024filed 19 Nov 2024 | R1 RCM Inc. /DEoption or derivative | SEC FORM 4 Code D | —515,715 | filing |
| 19 Nov 2024filed 19 Nov 2024 | R1 RCM Inc. /DE | SEC FORM 4 Code D | $1.3M87,765 at $14.30 | filing |
| 9 Jul 2024filed 11 Jul 2024 | ANIK Anika TherapeuticsMedical Devices | SEC FORM 4 Code A | —5,771 at $0.00 | filing |
| 20 Jun 2024filed 21 Jun 2024 | APRE Aprea Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —4,185 at $0.00 | filing |
News
Analyzing Anika Therapeutics (NASDAQ:ANIK) & ADMA Biologics (NASDAQ:ADMA)ANIK · dailypolitical.com · 13 Oct 2026SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duties by Certain Officers and Directors of Orthofix Medical Inc. (NASDAQ: OFIX)OFIX · prnewswire.com · 9 Oct 2026
0 headlines in the last 90 days name John B. Henneman III; 2 articles from the last 14 days about the 2 companies they traded most, at most three about any one of them.